Skip to main navigation
 logo

Top Menu

  • About Novelion
  • Press Releases
  • Filings
    • SEC Filings
    • Sedar Filings
    • SEDI Filings
    • Annual Reports & Proxies
  • Stock Information
    • Historic Stock Look-up
    • Dividend History
    • Ownership Profile
  • Governance
    • Management
    • Board of Directors
    • Contact the Board
 
  • About Novelion
  • Press Releases
  • Filings
    • SEC Filings
    • Sedar Filings
    • SEDI Filings
    • Annual Reports & Proxies
  • Stock Information
    • Historic Stock Look-up
    • Dividend History
    • Ownership Profile
  • Governance
    • Management
    • Board of Directors
    • Contact the Board

SEC Filing Details

Investor Relations

  • Press Releases
  • Corporate Governance
    • Management
    • Board of Directors
    • Contact the Board
  • Financial Information
    • SEC Filings
    • SEDAR Filings
    • SEDI Filings
    • Annual Reports and Proxies
    • Key Ratios
    • 8937-original
    • 8937-amended
  • Stock Information
    • Historic Stock Lookup
    • Investment Calculator
    • Dividend History
    • Analyst Coverage
    • Ownership Profile

Breadcrumb

Investors // Sec filings Sec filing 10 k 10-K //

SEC Filing Details

Document Details

Form
10-K
Filing Date
Mar 15, 2019
Document Date
Dec 31, 2018
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
Novelion Therapeutics
Issuer
NOVELION THERAPEUTICS INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
XML - XBRL INSTANCE DOCUMENT

Shareholder Tools

  • Share
  • Printed Docs
  • Print Page

  • Facebook
  • LinkedIn
  • Twitter
  • RSS

© 2019 Novelion Therapeutics Inc.
All rights reserved